Clinical Trial Update: A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, reactogenicity, and immunogenicity of a rotavirus vaccine in HIV-infected infants in South Africa; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• HRV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 2 | Status: COMPLETED | Results posted: 2009-03-13